Saudi Epilepsy Society consensus on epilepsy management during the COVID-19 Pandemic

Coronavirus disease 2019 (COVID-19) emerged in late 2019 in Wuhan, China.(1) The outbreak was confirmed as a pandemic on February 11, 2020, by the World Health Organization (WHO). By the end of April 2020, more than 3.5 million people were infected worldwide. The number of affected people in Saudi Arabia has reached more than 28,000 at the time of this report's submission. Since the early phase of the novel coronavirus epidemic, the Ministry of Health (MOH) in Saudi Arabia has been working to develop strict measures to contain the virus spread, going as far as locking down certain cities and restricting movement within and between others. The pandemic has affected all medical specialists' ability to practice efficiently and has resulted in a major change in the clinical pathways of managing people with epilepsy worldwide.(1) The Saudi Epilepsy Society (SES), in collaboration with the Saudi Patient Safety Center, has initiated a priority care classification in epilepsy management practice. In addition, the SES COVID-19 task force has established a consensus for the best evidence-based practice related to epilepsy during the pandemic.